Business Description
ASKA Pharmaceutical Holdings Co Ltd
ISIN : JP3119660003
Description
ASKA Pharmaceutical Holdings Co Ltd is engaged in the manufacturing, sale, import, export, clinical examinations and testing operations of pharmaceuticals, quasi-drugs, foods, veterinary drugs, feeds and feed additives and medical devices and related operations.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.01 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.17 | |||||
| Debt-to-EBITDA | 1.18 | |||||
| Interest Coverage | 130.07 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 3.39 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 60.89 | |||||
| 9-Day RSI | 60.22 | |||||
| 14-Day RSI | 59.83 | |||||
| 6-1 Month Momentum % | 27.13 | |||||
| 12-1 Month Momentum % | 66.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.88 | |||||
| Quick Ratio | 1.96 | |||||
| Cash Ratio | 0.95 | |||||
| Days Inventory | 206.76 | |||||
| Days Sales Outstanding | 100.49 | |||||
| Days Payable | 50.51 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.72 | |||||
| Dividend Payout Ratio | 0.18 | |||||
| Forward Dividend Yield % | 1.72 | |||||
| 5-Year Yield-on-Cost % | 1.72 | |||||
| Shareholder Yield % | 5.47 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 48.12 | |||||
| Operating Margin % | 9.02 | |||||
| Net Margin % | 10.5 | |||||
| FCF Margin % | 4.2 | |||||
| ROE % | 11.45 | |||||
| ROA % | 7.17 | |||||
| ROIC % | 6.52 | |||||
| ROC (Joel Greenblatt) % | 26.15 | |||||
| ROCE % | 12.04 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 9.98 | |||||
| PE Ratio without NRI | 14.95 | |||||
| PS Ratio | 1.1 | |||||
| PB Ratio | 1.07 | |||||
| Price-to-Tangible-Book | 1.13 | |||||
| Price-to-Free-Cash-Flow | 26.92 | |||||
| Price-to-Operating-Cash-Flow | 20.92 | |||||
| EV-to-EBIT | 6.39 | |||||
| EV-to-EBITDA | 6.39 | |||||
| EV-to-Revenue | 0.88 | |||||
| EV-to-FCF | 20.6 | |||||
| Price-to-Graham-Number | 0.87 | |||||
| Price-to-Net-Current-Asset-Value | 2.36 | |||||
| Earnings Yield (Greenblatt) % | 15.64 | |||||
| FCF Yield % | 4.02 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ASKA Pharmaceutical Holdings Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 62,026 | ||
| EPS (TTM) (円) | 230.02 | ||
| Beta | 0.68 | ||
| Volatility % | 21.48 | ||
| 14-Day RSI | 59.83 | ||
| 14-Day ATR (円) | 57.434468 | ||
| 20-Day SMA (円) | 2230.85 | ||
| 12-1 Month Momentum % | 66.15 | ||
| 52-Week Range (円) | 1207 - 2339 | ||
| Shares Outstanding (Mil) | 28.28 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ASKA Pharmaceutical Holdings Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ASKA Pharmaceutical Holdings Co Ltd Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
ASKA Pharmaceutical Holdings Co Ltd Frequently Asked Questions
What is ASKA Pharmaceutical Holdings Co Ltd(TSE:4886)'s stock price today?
The current price of TSE:4886 is 円2294.00. The 52 week high of TSE:4886 is 円2339.00 and 52 week low is 円1207.00.
When is next earnings date of ASKA Pharmaceutical Holdings Co Ltd(TSE:4886)?
The next earnings date of ASKA Pharmaceutical Holdings Co Ltd(TSE:4886) is .
Does ASKA Pharmaceutical Holdings Co Ltd(TSE:4886) pay dividends? If so, how much?
The Dividend Yield %  of ASKA Pharmaceutical Holdings Co Ltd(TSE:4886) is 1.72% (As of Today), Highest Dividend Payout Ratio of ASKA Pharmaceutical Holdings Co Ltd(TSE:4886) was 0.18. The lowest was 0.11. And the median was 0.12. The  Forward Dividend Yield % of ASKA Pharmaceutical Holdings Co Ltd(TSE:4886) is 1.72%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers